Abstract
Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50% of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25% in patients with systemic lupus erythematosus and 9% in healthy controls with a statistically significant difference (p
| Original language | English |
|---|---|
| Pages (from-to) | 59-62 |
| Number of pages | 4 |
| Journal | Clinical and Experimental Rheumatology |
| Volume | 5 |
| Issue number | 1 |
| Publication status | Published - 1987 |
Fingerprint
ASJC Scopus subject areas
- Immunology
- Rheumatology
Cite this
Mitral valve prolapse in systemic lupus erythematosus. / Barzizza, F.; Venco, A.; Grandi, A. M.; Finardi, G.
In: Clinical and Experimental Rheumatology, Vol. 5, No. 1, 1987, p. 59-62.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Mitral valve prolapse in systemic lupus erythematosus
AU - Barzizza, F.
AU - Venco, A.
AU - Grandi, A. M.
AU - Finardi, G.
PY - 1987
Y1 - 1987
N2 - Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50% of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25% in patients with systemic lupus erythematosus and 9% in healthy controls with a statistically significant difference (p
AB - Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50% of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25% in patients with systemic lupus erythematosus and 9% in healthy controls with a statistically significant difference (p
UR - http://www.scopus.com/inward/record.url?scp=0023204371&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023204371&partnerID=8YFLogxK
M3 - Article
VL - 5
SP - 59
EP - 62
JO - Clinical and Experimental Rheumatology
JF - Clinical and Experimental Rheumatology
SN - 0392-856X
IS - 1
ER -